Daiwa Securities Group Inc. - RA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of RA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$32,000
+146.2%
2660.0%0.00%
Q1 2020$13,000
+8.3%
2660.0%0.00%
Q4 2019$12,000
+71.4%
266
-11.3%
0.00%
Q3 2019$7,000
-12.5%
300
+12.4%
0.00%
Q2 2019$8,000
+33.3%
2670.0%0.00%
Q1 2019$6,000
+200.0%
267
+113.6%
0.00%
Q4 2018$2,0000.0%1250.0%0.00%
Q3 2018$2,000
+100.0%
1250.0%0.00%
Q2 2018$1,0000.0%1250.0%0.00%
Q1 2018$1,0001250.00%
Other shareholders
RA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 6,138,797$288,094,00013.62%
RA Capital Management 4,858,260$227,998,0006.91%
HAVENS ADVISORS LLC 116,000$5,444,0004.77%
ALPINE ASSOCIATES MANAGEMENT INC. 2,115,600$99,286,0003.16%
SYQUANT CAPITAL SAS 129,690$6,086,0003.13%
BARDIN HILL MANAGEMENT PARTNERS LP 391,758$18,386,0003.02%
Kellner Capital, LLC 91,100$4,275,0002.71%
Telemetry Investments, L.L.C. 17,100$803,0002.68%
Versor Investments LP 1,002,649$47,054,0002.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,519,718$71,320,0002.28%
View complete list of RA PHARMACEUTICALS INC shareholders